Esophageal Diseases  >>  Teysuno (gimeracil/oteracil/tegafur)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
FluoHeart, NCT02216149 / 2013-003976-11: Effects of S-1 and Capecitabine on Coronary Artery Blood Flow

Terminated
2
20
Europe
S-1, Teysuno, tegafur/gimeracil/oteracil, Capecitabine, Xeloda, Oxaliplatin, Eloxatin
Heikki Joensuu
Esophagus Cancer, Stomach Cancer, Small Bowel Cancer, Colon Cancer, Rectum Cancer
08/18
08/18
NCT01831531: Study of S-1 in Combination With Radiotherapy in Esophageal Cancer

Completed
2
105
RoW
S-1, Radiation therapy
Fudan University
Esophageal Squamous Cell Carcinoma
10/18
10/18

Download Options